SCHEMBL22819201

SCHEMBL22819201

C=CC(=O)Nc1cc(Nc2cc(Nc3ccccc3N(C)SC)ncn2)c(OC)cc1N(C)CCN(C)C

nearest known ligand 0.65

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.65
ALK Q9UM73 3/20 0.62
EML4 Q9HC35 2/20 0.61
ERBB3 P21860 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22806784 0.89 EGFR (0.65) EGFRALKEML4ERBB3
Phosphine SCHEMBL22806798 0.89 EGFR (0.64) EGFRALKEML4ERBB3
SCHEMBL22819312 0.85 EGFR (0.78) EGFRALKEML4
SCHEMBL35210347 0.84 EGFR (0.61) EGFRALKEML4
SCHEMBL19089670 0.84 EGFR (0.61) EGFRALKEML4
SCHEMBL35210286 0.84 EGFR (0.61) EGFRALKEML4
SCHEMBL20548806 0.84 EGFR (0.61) EGFRALKEML4
SCHEMBL24662635 0.83 EGFR (0.83) EGFRALKEML4ERBB3
SCHEMBL24663098 0.83 EGFR (0.84) EGFRALKEML4ERBB3
SCHEMBL29936740 0.83 EGFR (0.84) EGFRALKEML4ERBB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020256477-A1 PYRIMIDINE DERIVATIVE INHIBITING GROWTH OF CANCER CELL AND MEDICINAL USE THEREOF 주식회사 온코빅스 2020-12-24 WO disclosed